Direct Line Group appoints new CFO Tim Harris

Direct Line Insurance Group PLC

Direct Line Insurance Group plc (LON: DLG) announced today that Tim Harris will join the Company as Chief Financial Officer and the Board as an Executive Director on 1st October 2019.

Tim was Deputy Chief Executive and Group Finance Director of the Royal London Group until 12 July 2019. He joined Royal London as Group Finance Director in May 2014 and was additionally appointed as Deputy Chief Executive in January 2018. Before joining Royal London, Tim had been Group CFO of Torus Insurance, Deputy Group CFO and Chief Capital Officer of Aviva plc and a Partner in the Global Capital Markets practice of PricewaterhouseCoopers.

Mike Biggs, Direct Line Insurance Group Chairman, said:

‘I am delighted to welcome Tim to the Direct Line Group Board, which will benefit from his many years of experience as a leading finance director in the insurance industry.’

Penny James, CEO, Direct Line Group, said:

‘Tim is a great fit with Direct Line Group’s culture and will contribute a wealth of experience. I am delighted that he is joining Direct Line Group and am very much looking forward to working with him.’

Tim Harris said:

‘Direct Line Group is a business admired for putting the customer first and for its passion for diversity and innovation. I am excited to be joining its excellent management team as the Group leverages the strength of its market position to take advantage of future opportunities.’

Note

  1. Tim Harris will receive an annual salary of £535,000 and a pension allowance of 9% of salary. He will also be able to participate in the Company’s existing annual incentive plan up to a maximum of 175% of salary and the long term incentive plan up to 200% of salary per annum. Tim will also receive awards to compensate for remuneration arrangements forfeited on leaving his previous employer. All remuneration arrangements are consistent with the terms of the Directors’ Remuneration Policy approved by shareholders at the AGM in May 2017.
  2. No other information is required to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules in relation to Tim’s appointment as a Director of the Company.
Share on:

Latest Company News

Ur-Energy advances Lost Soldier uranium project

Ur-Energy has commenced baseline fieldwork at its Lost Soldier uranium project in Wyoming and expects to publish a technical...

Rhythm Pharmaceuticals reports sustained BMI reductions in two-year obesity trial

Rhythm Pharmaceuticals has reported sustained BMI reductions after two years of setmelanotide treatment in patients with acquired hypothalamic obesity....

Verici Dx provides PTRA testing for phase 2 organ transplant clinical trial

Verici Dx has secured an order from Asahi Kasei Therapeutics to provide blood-based biomarker testing, including its PTRA assay,...

Elemental reports record revenue and expands royalty portfolio following Orion acquisition

Elemental Royalty Corporation reported record year-to-date revenue of almost US$70m and approximately 15,100 gold equivalent ounces for the first...

Telecom operators risk failed transformations without clear business plans

Telecom operators risk wasting millions on technology upgrades without clear business objectives. Successful transformation requires simpler processes, executive accountability...

Worldwide Healthcare Trust H1 2026 results impress with 14.8% total return (LON: WWH)

Worldwide Healthcare Trust has reported a 9.3% NAV total return and a 14.8% share price total return for the...

    Search